Covid-19 Research


COVID-19 research at UCL

At UCL we are applying the depth and breadth of our cross-disciplinary research and expertise to help humanity recover from COVID-19 and to make the world more resilient and equitable in the future.

Our experts are urgently researching new ways of tackling the COVID-19 pandemic and are taking a prominent role in advancing public knowledge by advising world leaders, collaborating with key partners and providing expert commentary to inform the media.

UCL Quad

Our response and strengths

UCL is uniquely placed to respond, not only to the current crisis but to develop informed solutions for the future. Find out about our strengths and direction. 

research laboratory

Working in partnership

We are rallying our collective expertise to address the urgent issues posed by COVID-19.
Covid-19 experts

Our research and expertise

UCL researchers are working across disciplines, to help find a cure, improve diagnosis, and advise Government in the UK and globally.

news essentials


For all the latest news and articles featuring UCL academics and expertise on Covid-19.

UCL coronavirus response fund

Coronavirus Response Fund

Help us tackle the pandemic by donating to our research fund.

magnifying glass

Information for UCL reseachers

Check this section for information on research and funding opportunities, and on new project submissions.  


Call for participants: Storm Chaser Trial 

The research team have just opened a new clinical trial for people who have been exposed to someone with confirmed COVID-19 in the last 8 days. The experimental treatment is with a monoclonol antibody and the trial is being run at the UCLH Clinical Research Facility. It is sponsored by Astrazeneca. The purpose of this trial is to test whether a new drug can prevent or treat COVID-19. Please email the trials team if you are interested in participating: uclh.stormchaser@nhs.net or call +44 (0) 203 151 3117. 

1 December 2020

Tablets of antiviral drugs
Antiviral drugs trialled in the early stages of COVID-19

Two antiviral drugs are being given to COVID-19 positive adults to establish if they stop the virus replicating, as part of a trial led by UCL scientists.

28 October 2020

Professor Rebecca Shipley, left, and a member of the HPP team. Credit: Jude Palmer / Royal Academy of Engineering
Team behind life-saving breathing aid win prestigious engineering award
UCL engineers and medics who developed a CPAP breathing aid now used in hospitals across the UK have received an award from the Royal Academy of Engineering for exceptional services during a pandemic.
17 August 2020  

Covid-19 cells
New study into Covid-19 transmission and immunity launched
UCL has launched Virus Watch, inviting 42,500 people to take part in one of the largest and most comprehensive studies of Covid-19 in the UK to study the next phase of the pandemic.
23 June 2020


More Covid-19 news and articles